PTGX Q1 2026 Earnings Surprise Profitability Defies Estimates Amid No Revenue NTLA Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Stage Company Focuses on Pipeline Execution Day One Biopharmaceuticals Q4 2025 Earnings EPS Miss Amid Continued RD Investment RDNW Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Reaction LECO Q1 2026 Earnings Modest EPS Beat Amidst Steady Operational Performance GDS Holdings Q1 2026 Earnings Stunning EPS Beat of 132 vs Expected Loss